🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 107 of 114

  1. eRapa (encapsulated rapamycin)

    Biodexa Pharmaceuticals Plc

    Familial Adenomatous Polyposis (FAP)

    phase 3 small molecule active

    1 trial

  2. ecallantide

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    4 trials

  3. edoxaban tosylate(DU-176b)

    Daiichi Sankyo

    Venous Thromboembolism

    phase 3 small molecule completed

    1 trial

  4. educational internet site on prostate cancer screening

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 other completed

    1 trial

  5. efgartigimod PH20 SC

    argenx

    Bullous Pemphigoid

    phase 3 mab completed

    1 trial

  6. elafibranor, Elafibranor Placebo

    Ipsen

    Primary Biliary Cholangitis (PBC)

    phase 3 small molecule active

    1 trial

  7. elafibranor, Placebo

    Ipsen

    Primary Biliary Cholangitis

    phase 3 small molecule active

    1 trial

  8. elafibranor, Placebo tablet

    Ipsen

    Primary Biliary Cholangitis

    phase 3 small molecule active

    1 trial

  9. elritercept, Placebo to match ker-050 solution for injection

    Takeda

    myelodysplastic neoplasms/syndromes (MDS)

    phase 3 small molecule active

    1 trial

  10. eltrombopag

    GlaxoSmithKline

    Hepatitis C, Chronic

    phase 3 small molecule completed

    1 trial

  11. eltrombopag

    GlaxoSmithKline

    Purpura, Thrombocytopaenic, Idiopathic

    phase 3 small molecule completed

    2 trials

  12. enfortumab vedotin, VINFLUNINE , DOCETAXEL , PACLITAXEL

    Astellas Pharma GmbH

    Locally advanced or metastatic urothelial cancer

    phase 3 small molecule active

    1 trial

  13. enzastaurin

    Eli Lilly and Company

    Glioblastoma

    phase 3 small molecule completed

    1 trial

  14. epinephrine inhalation aerosol

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    2 trials

  15. eptacog alfa (activated)

    Novo Nordisk A/S

    Acquired Bleeding Disorder

    phase 3 small molecule completed

    1 trial

  16. erlotinib

    Hoffmann-La Roche

    Non-Squamous Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  17. esophagectomy

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 other active

    1 trial

  18. eteplirsen

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy (DMD)

    phase 3 small molecule completed

    2 trials

  19. evinacumab

    Regeneron UK Limited

    Homozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    3 trials

  20. evogliptin

    Dong Wang

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  21. evorpacept, Herceptin 150 mg powder for concentrate for solution for infusion, Cyramza 10 mg/ml concentrate for solution for infusion, Paclitaxel 6 mg/mL concentrate for solution for infusion, Normal Saline (Sodium Chloride)

    Wuhan Createrna Science and Technology Co., Ltd

    Patients with HER2-overexpressing advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma that has progressed on or after a prior HER2-directed agent and fluoropyrimidine- or platinum-containing chemotherapy (2nd-line or 3rd-line)

    phase 3 small molecule active

    1 trial

  22. exemestane

    Partner Therapeutics Limited

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  23. exenatide once weekly

    AstraZeneca

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  24. experimental anti-anxiety drug

    Jazz Pharmaceuticals Ireland Limited

    Anxiety Disorder

    phase 3 small molecule completed

    1 trial

  25. experimental vaccine

    Sinovac Research and Development Co.,

    Epidemic Meningitis

    phase 3 mab active

    4 trials

  26. extended-release guanfacine hydrochloride (SPD503)

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    phase 3 small molecule completed

    1 trial

  27. extended-release naltrexone (XR-NTX)

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine-dependence

    phase 3 small molecule active

    1 trial

  28. eythrocytapheresis

    Atrium Therapeutics

    Pre Operative Autologous Donation

    phase 3 other completed

    1 trial

  29. favezelimab/pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Colorectal Cancer

    phase 3 mab completed

    1 trial

  30. fexofenadine HCL (M016455)

    Sanofi Pasteur

    Rhinitis Seasonal

    phase 3 small molecule completed

    1 trial

  31. fianlimab

    Regeneron UK Limited

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  32. fianlimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  33. filgrastim

    Solid Biosciences

    Lung Cancer

    phase 3 mab active

    1 trial

  34. filgrastim

    Hospital Authority, Hong Kong

    Brain and Central Nervous System Tumors

    phase 3 mab completed

    2 trials

  35. filgrastim

    Solid Biosciences

    Lymphoma

    phase 3 mab active

    2 trials

  36. filgrastim

    Solid Biosciences

    Ovarian Cancer

    phase 3 mab completed

    1 trial

  37. filgrastim

    Children's Hospital of Fudan University

    Neuroblastoma

    phase 3 mab completed

    1 trial

  38. fitusiran

    Sanofi Pasteur

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  39. fixed dose combination of telmisartan+amlodipine

    Boehringer Ingelheim

    Hypertension

    phase 3 small molecule completed

    1 trial

  40. fluocinolone acetonide

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema

    phase 3 small molecule completed

    3 trials

  41. fluticasone furoate/vilanterol

    GlaxoSmithKline

    Pulmonary Disease, Chronic Obstructive

    phase 3 small molecule completed

    1 trial

  42. folic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial

  43. formoterol

    Pacira Ireland Limited

    Asthma

    phase 3 other completed

    1 trial

  44. furmonertinib 240 mg oral, daily

    ArriVent BioPharma

    Metastatic Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  45. gabapentin

    Pfizer

    Epilepsies, Partial

    phase 3 small molecule completed

    1 trial

  46. ganciclovir

    Ultragenyx UK Limited

    Cytomegalovirus Infections

    phase 3 small molecule completed

    1 trial

  47. garetosmab

    Regeneron UK Limited

    Fibrodyplasia Ossificans Progressiva (FOP)

    phase 3 small molecule terminated

    1 trial

  48. garetosmab

    Regeneron UK Limited

    Fibrodysplasia Ossificans Progressiva (FOP)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.